MetaADEDB 2.0 @ LMMD
fluticasone furoate
(XTULMSXFIHGYFS-VLSRWLAYSA-N)
Structure
SMILES
FCSC(=O)[C@@]1(OC(=O)c2ccco2)[C@H](C)C[C@@H]2[C@]1(C)C[C@H](O)[C@]1([C@H]2C[C@@H](C2=CC(=O)C=C[C@]12C)F)F
Type(s)
Approved
ATC code(s)
R01AD12; R03AK10; R03AL08; R03BA09
Molecular Formula:
C27H29F3O6S
Molecular Weight:
538.576
Log P:
4.9268
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
1
TPSA:
119.11
CAS Number(s):
397864-44-7; 779352-12-4; 911210-90-7
Synonym(s)
1.
fluticasone furoate
External Link(s)
MeSHC523187
PubChem Compound9854489
BindingDB50354851
ChEBI74899
CHEMBLCHEMBL1676
DrugBankDB08906
DrugCentral4554
KEGGdr:D06315
ZINC3992105
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 346
Canada Vigilance: 12
Canada Vigilance
US FAERS
2Product quality issueFAERS: 227
Canada Vigilance: 2
Canada Vigilance
US FAERS
3EpistaxisFAERS: 127
Canada Vigilance: 8
Canada Vigilance
US FAERS
4Wrong technique in device usage processFAERS: 96US FAERS
5Wrong technique in product usage processFAERS: 91
Canada Vigilance: 1
Canada Vigilance
US FAERS
6Product use in unapproved indicationFAERS: 89US FAERS
7HeadacheFAERS: 87
Canada Vigilance: 7
Canada Vigilance
US FAERS
8Product complaintFAERS: 69
Canada Vigilance: 10
Canada Vigilance
US FAERS
9Nasal discomfortFAERS: 58US FAERS
10Drug dose omissionFAERS: 57US FAERS
11DizzinessFAERS: 56
Canada Vigilance: 1
Canada Vigilance
US FAERS
12AnosmiaFAERS: 54
Canada Vigilance: 4
Canada Vigilance
US FAERS
13Device use errorFAERS: 51US FAERS
14OverdoseFAERS: 45US FAERS
15HypersensitivityFAERS: 41US FAERS
16Accidental exposure to productFAERS: 36US FAERS
17AsthmaFAERS: 35
Canada Vigilance: 3
Canada Vigilance
US FAERS
18Incorrect dose administeredFAERS: 34US FAERS
19DysphoniaFAERS: 33US FAERS
20NauseaFAERS: 33
Canada Vigilance: 2
Canada Vigilance
US FAERS
21MalaiseFAERS: 31
Canada Vigilance: 1
Canada Vigilance
US FAERS
22Oropharyngeal painFAERS: 30
Canada Vigilance: 2
Canada Vigilance
US FAERS
23Inappropriate schedule of drug administrationFAERS: 28US FAERS
24FatigueFAERS: 25
Canada Vigilance: 2
Canada Vigilance
US FAERS
25Product use issueFAERS: 25US FAERS
26AgeusiaFAERS: 24
Canada Vigilance: 4
Canada Vigilance
US FAERS
27Extra dose administeredFAERS: 22US FAERS
28CataractFAERS: 21
Canada Vigilance: 3
Canada Vigilance
US FAERS
29Drug ineffective for unapproved indicationFAERS: 21US FAERS
30Inappropriate schedule of product administrationFAERS: 21US FAERS
31SinusitisFAERS: 21US FAERS
32Drug effect incompleteFAERS: 20US FAERS
33Product dispensing errorFAERS: 20US FAERS
34Therapeutic response unexpectedFAERS: 20US FAERS
35Throat irritationFAERS: 20
Canada Vigilance: 1
Canada Vigilance
US FAERS
36PainFAERS: 19
Canada Vigilance: 2
Canada Vigilance
US FAERS
37AnxietyFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
38UrticariaFAERS: 18
Canada Vigilance: 3
Canada Vigilance
US FAERS
39Chest discomfortFAERS: 17
Canada Vigilance: 3
Canada Vigilance
US FAERS
40Drug effective for unapproved indicationFAERS: 17US FAERS
41DysgeusiaFAERS: 17
Canada Vigilance: 2
Canada Vigilance
US FAERS
42SneezingFAERS: 17US FAERS
43VomitingFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
44Back PainFAERS: 16
Canada Vigilance: 4
Canada Vigilance
US FAERS
45Drug administration errorFAERS: 16US FAERS
46Eye painFAERS: 16US FAERS
47ErythemaFAERS: 15
Canada Vigilance: 2
Canada Vigilance
US FAERS
48Product dose omissionFAERS: 15US FAERS
49AstheniaFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
50Drug administered to patient of inappropriate ageFAERS: 14US FAERS
51Feeling abnormalFAERS: 14US FAERS
52GlaucomaFAERS: 14
Canada Vigilance: 3
Canada Vigilance
US FAERS
53PalpitationsFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
54Medication ErrorFAERS: 13US FAERS
55Pharmaceutical product complaintFAERS: 13US FAERS
56PneumoniaFAERS: 13US FAERS
57Product package associated injuryFAERS: 13US FAERS
58PruritusFAERS: 13US FAERS
59RhinalgiaFAERS: 13
Canada Vigilance: 2
Canada Vigilance
US FAERS
60SomnolenceFAERS: 13US FAERS
61Adverse eventFAERS: 12US FAERS
62Expired product administeredFAERS: 12US FAERS
63Eye irritationFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
64NasopharyngitisFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
65Sinus headacheFAERS: 12US FAERS
66WheezingFAERS: 12US FAERS
67Burning sensationFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
68Ear discomfortFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
69Intentional product misuseFAERS: 10US FAERS
70Prescribed overdoseFAERS: 10US FAERS
71Product storage errorFAERS: 10US FAERS
72Visual ImpairmentFAERS: 10US FAERS
73Accidental overdoseFAERS: 9US FAERS
74Circumstance or information capable of leading to medication errorFAERS: 9US FAERS
75Incorrect product administration durationFAERS: 9US FAERS
76LacerationFAERS: 9US FAERS
77TinnitusFAERS: 9US FAERS
78BronchitisFAERS: 8US FAERS
79Incorrect drug administration durationFAERS: 8US FAERS
80Nasal inflammationFAERS: 8US FAERS
81AngioedemaFAERS: 7US FAERS
82Chest PainFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
83ChokingFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
84Drug prescribing errorFAERS: 7US FAERS
85Feeling jitteryFAERS: 7US FAERS
86Oropharyngeal discomfortFAERS: 7US FAERS
87Product container issueFAERS: 7US FAERS
88Productive CoughFAERS: 7US FAERS
89Upper-airway cough syndromeFAERS: 7US FAERS
90Abdominal discomfortFAERS: 6US FAERS
91ArthralgiaFAERS: 6US FAERS
92Blood cortisol decreasedFAERS: 6US FAERS
93Contraindicated product administeredFAERS: 6US FAERS
94InfectionFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
95Lip swellingFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
96MyalgiaFAERS: 6US FAERS
97Oral candidiasisFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
98VertigoFAERS: 6US FAERS
99Abdominal PainFAERS: 5US FAERS
100FlushingFAERS: 5US FAERS
101Growth retardationFAERS: 5US FAERS
102InfluenzaFAERS: 5US FAERS
103Peripheral swellingFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
104Product cleaning inadequateFAERS: 5US FAERS
105Product label confusionFAERS: 5US FAERS
106SwellingFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
107Weight decreasedFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
108AphoniaFAERS: 4US FAERS
109BronchospasmFAERS: 4US FAERS
110Cataract operationFAERS: 4US FAERS
111DiplopiaFAERS: 4US FAERS
112EncephalitisFAERS: 4US FAERS
113Head discomfortFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
114Inability to afford medicationFAERS: 4US FAERS
115Increased upper airway secretionFAERS: 4US FAERS
116Nasal mucosal disorderFAERS: 4US FAERS
117Nasal pruritusFAERS: 4US FAERS
118NervousnessFAERS: 4US FAERS
119Ocular discomfortFAERS: 4US FAERS
120Paranasal sinus discomfortFAERS: 4US FAERS
121RhinitisFAERS: 4US FAERS
122SyncopeFAERS: 4US FAERS
123AcneFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
124AgitationFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
125AneurysmFAERS: 3US FAERS
126Angina PectorisFAERS: 3US FAERS
127Auricular swellingFAERS: 3US FAERS
128Blood glucose increasedFAERS: 3US FAERS
129CellulitisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
130ConstipationFAERS: 3US FAERS
131CryingFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
132Depressed Level of ConsciousnessFAERS: 3US FAERS
133Device malfunctionFAERS: 3US FAERS
134DiscomfortFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
135Drug dispensing errorFAERS: 3US FAERS
136Drug exposure during pregnancyFAERS: 3US FAERS
137Emergency care examinationFAERS: 3US FAERS
138Facial PainFAERS: 3US FAERS
139Incorrect route of product administrationFAERS: 3US FAERS
140InflammationFAERS: 3US FAERS
141Intercepted drug administration errorFAERS: 3US FAERS
142Intercepted medication errorFAERS: 3US FAERS
143LaryngitisFAERS: 3US FAERS
144LymphadenopathyFAERS: 3US FAERS
145Myocardial InfarctionFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
146Oral painFAERS: 3US FAERS
147Oropharyngeal swellingFAERS: 3US FAERS
148PharyngitisFAERS: 3US FAERS
149PhotophobiaFAERS: 3US FAERS
150PleurisyFAERS: 3US FAERS
151Product prescribing issueFAERS: 3US FAERS
152Rash erythematousFAERS: 3US FAERS
153Rebound effectFAERS: 3US FAERS
154RetchingFAERS: 3US FAERS
155ScabFAERS: 3US FAERS
156Secretion dischargeFAERS: 3US FAERS
157TachycardiaFAERS: 3US FAERS
158Therapeutic procedureFAERS: 3US FAERS
159ThrombosisFAERS: 3US FAERS
160TremorFAERS: 3US FAERS
161Visual disturbanceFAERS: 3US FAERS
162Accidental exposure to product packagingFAERS: 2US FAERS
163Accidental exposureFAERS: 2US FAERS
164AlopeciaFAERS: 2US FAERS
165AmnesiaFAERS: 2US FAERS
166Anaphylactic shockFAERS: 2US FAERS
167Anaphylactoid ReactionFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
168Angle Closure GlaucomaFAERS: 2US FAERS
169AsphyxiaFAERS: 2US FAERS
170Atrial FibrillationFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
171BlepharospasmFAERS: 2US FAERS
172Blood glucose decreasedFAERS: 2US FAERS
173Cerebrovascular accidentFAERS: 2US FAERS
174ChillsFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
175Decreased immune responsivenessFAERS: 2US FAERS
176Diabetes MellitusFAERS: 2US FAERS
177Diabetes mellitus inadequate controlFAERS: 2US FAERS
178Disease recurrenceFAERS: 2US FAERS
179Drug DependenceFAERS: 2US FAERS
180DysenteryFAERS: 2US FAERS
181Emotional distressFAERS: 2US FAERS
182Eyelid irritationFAERS: 2US FAERS
183Flank PainFAERS: 2US FAERS
184FlatulenceFAERS: 2US FAERS
185Foreign body aspirationFAERS: 2US FAERS
186HyperinsulinismFAERS: 2US FAERS
187HypersomniaFAERS: 2US FAERS
188Hypertensive crisisFAERS: 2US FAERS
189Hypoaesthesia facialFAERS: 2US FAERS
190HypotensionFAERS: 2US FAERS
191ImmobileFAERS: 2US FAERS
192Incorrect product storageFAERS: 2US FAERS
193Intentional product use issueFAERS: 2US FAERS
194Intercepted drug dispensing errorFAERS: 2US FAERS
195Intercepted drug prescribing errorFAERS: 2US FAERS
196Joint swellingFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
197Limb injuryFAERS: 2US FAERS
198MetamorphopsiaFAERS: 2US FAERS
199Molluscum ContagiosumFAERS: 2US FAERS
200Multiple allergiesFAERS: 2US FAERS
201Muscle tightnessFAERS: 2US FAERS
202Musculoskeletal discomfortFAERS: 2US FAERS
203Musculoskeletal stiffnessFAERS: 2US FAERS
204MyopiaFAERS: 2US FAERS
205NeutropeniaFAERS: 2US FAERS
206Nonspecific reactionFAERS: 2US FAERS
207Oral fungal infectionFAERS: 2US FAERS
208Ovarian enlargementFAERS: 2US FAERS
209PoisoningFAERS: 2US FAERS
210Poor quality sleepFAERS: 2US FAERS
211Product administered at inappropriate siteFAERS: 2US FAERS
212Product packaging issueFAERS: 2US FAERS
213Respiratory tract irritationFAERS: 2US FAERS
214RosaceaFAERS: 2US FAERS
215Sinus operationFAERS: 2US FAERS
216Sinus painFAERS: 2US FAERS
217StomatitisFAERS: 2US FAERS
218Therapeutic product effect incompleteFAERS: 2US FAERS
219Therapeutic response changedFAERS: 2US FAERS
220Ultrasound scan abnormalFAERS: 2US FAERS
221Vitreous floatersFAERS: 2US FAERS
222Vulvovaginal mycotic infectionFAERS: 2US FAERS
223AbasiaFAERS: 1US FAERS
224AbscessFAERS: 1US FAERS
225Acute Coronary SyndromeFAERS: 1US FAERS
226Adenoidal disorderFAERS: 1US FAERS
227Adrenal massFAERS: 1US FAERS
228AngerFAERS: 1US FAERS
229Anticoagulation drug level above therapeuticFAERS: 1US FAERS
230Application site erosionFAERS: 1US FAERS
231Application site painFAERS: 1US FAERS
232Artificial crown procedureFAERS: 1US FAERS
233Atrophic vulvovaginitisFAERS: 1US FAERS
234Back disorderFAERS: 1US FAERS
235Bacterial rhinitisFAERS: 1US FAERS
236BlindnessFAERS: 1US FAERS
237Blood creatine phosphokinase increasedFAERS: 1US FAERS
238Blood glucose fluctuationFAERS: 1US FAERS
239Blood sodium decreasedFAERS: 1US FAERS
240Bone painFAERS: 1US FAERS
241Borderline glaucomaFAERS: 1US FAERS
242Borrelia test positiveFAERS: 1US FAERS
243Brain natriuretic peptide increasedFAERS: 1US FAERS
244BronchopneumoniaFAERS: 1US FAERS
245Cardiac FlutterFAERS: 1US FAERS
246Catheter placementFAERS: 1US FAERS
247CheilitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
248ChemotherapyFAERS: 1US FAERS
249Choking sensationFAERS: 1US FAERS
250CholelithiasisFAERS: 1US FAERS
251Circumstance or information capable of leading to device use errorFAERS: 1US FAERS
252Complication associated with deviceFAERS: 1US FAERS
253Compression fractureFAERS: 1US FAERS
254Concomitant disease aggravatedFAERS: 1US FAERS
255CystFAERS: 1US FAERS
256Dacryostenosis acquiredFAERS: 1US FAERS
257Deep Vein ThrombosisFAERS: 1US FAERS
258DehydrationFAERS: 1US FAERS
259Dental cariesFAERS: 1US FAERS
260DependenceFAERS: 1US FAERS
261Depressed moodFAERS: 1US FAERS
262DermatitisFAERS: 1US FAERS
263DisorientationFAERS: 1US FAERS
264DroolingFAERS: 1US FAERS
265Drug effect delayedFAERS: 1US FAERS
266Drug effect variableFAERS: 1US FAERS
267Drug screen positiveFAERS: 1US FAERS
268Drug toxicityFAERS: 1US FAERS
269DyspepsiaFAERS: 1US FAERS
270ElectrocardiogramFAERS: 1US FAERS
271Elevated moodFAERS: 1US FAERS
272Emergency CareFAERS: 1US FAERS
273Emotional disorderFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
274Endodontic procedureFAERS: 1US FAERS
275Environmental ExposureFAERS: 1US FAERS
276Erectile dysfunctionFAERS: 1US FAERS
277Erection increasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
278EructationFAERS: 1US FAERS
279Erythema MultiformeFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
280Euphoric moodFAERS: 1US FAERS
281Eye InfectionFAERS: 1US FAERS
282Eye inflammationFAERS: 1US FAERS
283Eyelid painFAERS: 1US FAERS
284Eyelids pruritusFAERS: 1US FAERS
285Facial ParesisFAERS: 1US FAERS
286Failure to ThriveFAERS: 1US FAERS
287Fluid overloadFAERS: 1US FAERS
288Food AllergyFAERS: 1US FAERS
289Foreign body in respiratory tractFAERS: 1US FAERS
290Frustration tolerance decreasedFAERS: 1US FAERS
291Fungal rhinitisFAERS: 1US FAERS
292Gastric ulcerFAERS: 1US FAERS
293Gastrointestinal candidiasisFAERS: 1US FAERS
294General physical health deteriorationFAERS: 1US FAERS
295GlossitisFAERS: 1US FAERS
296HordeolumFAERS: 1US FAERS
297HyperventilationFAERS: 1US FAERS
298HypogeusiaFAERS: 1US FAERS
299Iatrogenic injuryFAERS: 1US FAERS
300ImmunosuppressionFAERS: 1US FAERS
301Impaired driving abilityFAERS: 1US FAERS
302Impaired work abilityFAERS: 1US FAERS
303Increased bronchial secretionFAERS: 1US FAERS
304Increased tendency to bruiseFAERS: 1US FAERS
305Increased viscosity of bronchial secretionFAERS: 1US FAERS
306Increased viscosity of upper respiratory secretionFAERS: 1US FAERS
307IndurationFAERS: 1US FAERS
308Intentional device misuseFAERS: 1US FAERS
309Intentional dose omissionFAERS: 1US FAERS
310Intercepted product prescribing errorFAERS: 1US FAERS
311Intercepted product storage errorFAERS: 1US FAERS
312Keratoconjunctivitis SiccaFAERS: 1US FAERS
313Keratosis pilarisFAERS: 1US FAERS
314Lactose IntoleranceFAERS: 1US FAERS
315LaryngospasmFAERS: 1US FAERS
316LethargyFAERS: 1US FAERS
317LeukocytosisFAERS: 1US FAERS
318Lip exfoliationFAERS: 1US FAERS
319Living in residential institutionFAERS: 1US FAERS
320Lower respiratory tract infectionFAERS: 1US FAERS
321Mastication disorderFAERS: 1US FAERS
322Medication residueFAERS: 1US FAERS
323Middle insomniaFAERS: 1US FAERS
324Mood swingsFAERS: 1US FAERS
325Mouth swellingFAERS: 1US FAERS
326Muscle FatigueFAERS: 1US FAERS
327Musculoskeletal chest painFAERS: 1US FAERS
328MydriasisFAERS: 1US FAERS
329MyopathyFAERS: 1US FAERS
330Nasal mucosa atrophyFAERS: 1US FAERS
331Nasal mucosal erosionFAERS: 1US FAERS
332Nasal mucosal ulcerFAERS: 1US FAERS
333Nasal turbinate abnormalityFAERS: 1US FAERS
334NegativismFAERS: 1US FAERS
335NephrolithiasisFAERS: 1US FAERS
336NeuralgiaFAERS: 1US FAERS
337No adverse eventFAERS: 1US FAERS
338No adverse reactionFAERS: 1US FAERS
339Ocular HypertensionFAERS: 1US FAERS
340Olfactory Nerve DisorderFAERS: 1US FAERS
341OnychalgiaFAERS: 1US FAERS
342OnychoclasisFAERS: 1US FAERS
343Optic AtrophyFAERS: 1US FAERS
344Optic NeuritisFAERS: 1US FAERS
345Oral mucosal erythemaFAERS: 1US FAERS
346Oropharyngeal blisteringFAERS: 1US FAERS
347OsteopeniaFAERS: 1US FAERS
348Otitis MediaFAERS: 1US FAERS
349Pain of skinFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
350Palatal swellingFAERS: 1US FAERS
351Pancreatic carcinomaFAERS: 1US FAERS
352ParasomniaFAERS: 1US FAERS
353Performance status decreasedFAERS: 1US FAERS
354Personality ChangeFAERS: 1US FAERS
355PetechiaeFAERS: 1US FAERS
356Pharyngolaryngeal PainFAERS: 1US FAERS
357Pharyngolaryngeal abscessFAERS: 1US FAERS
358PolyneuropathyFAERS: 1US FAERS
359Poor quality drug administeredFAERS: 1US FAERS
360Prescribed underdoseFAERS: 1US FAERS
361Prescription drug used without a prescriptionFAERS: 1US FAERS
362PresyncopeFAERS: 1US FAERS
363Product administration errorFAERS: 1US FAERS
364Product appearance confusionFAERS: 1US FAERS
365Product communication issueFAERS: 1US FAERS
366Product contamination physicalFAERS: 1US FAERS
367Product prescribing errorFAERS: 1US FAERS
368Product substitution issueFAERS: 1US FAERS
369Product supply issueFAERS: 1US FAERS
370Pseudomonas bronchitisFAERS: 1US FAERS
371Pulmonary Valve StenosisFAERS: 1US FAERS
372Pulmonary congestionFAERS: 1US FAERS
373Pulmonary painFAERS: 1US FAERS
374PurulenceFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
375Reaction to drug excipientsFAERS: 1US FAERS
376Reaction to preservativesFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
377Rehabilitation therapyFAERS: 1US FAERS
378Respiratory distressFAERS: 1US FAERS
379Respiratory tract infection viralFAERS: 1US FAERS
380Retinal DetachmentFAERS: 1US FAERS
381RetinoschisisFAERS: 1US FAERS
382RhabdomyolysisFAERS: 1US FAERS
383Rheumatoid ArthritisFAERS: 1US FAERS
384Saliva analysis abnormalFAERS: 1US FAERS
385ScotomaFAERS: 1US FAERS
386Skin irritationFAERS: 1US FAERS
387Skin lacerationFAERS: 1US FAERS
388Skin lesionFAERS: 1US FAERS
389Skin reactionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
390Small cell lung cancer extensive stageFAERS: 1US FAERS
391SomnambulismFAERS: 1US FAERS
392Stem cell transplantFAERS: 1US FAERS
393StressFAERS: 1US FAERS
394Sudden deathFAERS: 1US FAERS
395Swelling of eyelidFAERS: 1US FAERS
396Tendon discomfortFAERS: 1US FAERS
397Therapeutic product effect decreasedFAERS: 1US FAERS
398ThirstFAERS: 1US FAERS
399Throat cancerFAERS: 1US FAERS
400Throat clearingFAERS: 1US FAERS
401ThrombocytopeniaFAERS: 1US FAERS
402Tongue blisteringFAERS: 1US FAERS
403Tongue discomfortFAERS: 1US FAERS
404Tooth repairFAERS: 1US FAERS
405Transcription medication errorFAERS: 1US FAERS
406Transmission of an infectious agent via a medicinal productFAERS: 1US FAERS
407Tympanic Membrane PerforationFAERS: 1US FAERS
408Upper respiratory tract congestionFAERS: 1US FAERS
409Urinary RetentionFAERS: 1US FAERS
410Urinary tract infectionFAERS: 1US FAERS
411VIIth nerve paralysisFAERS: 1US FAERS
412Viral upper respiratory tract infectionFAERS: 1US FAERS
413Vitreous DetachmentFAERS: 1US FAERS
414Waist circumference increasedFAERS: 1US FAERS
415cancer surgeryFAERS: 1US FAERS
416furuncleFAERS: 1US FAERS
417jaundiceFAERS: 1US FAERS
418Product impurityCanada Vigilance: 1Canada Vigilance
419Product lot number issueCanada Vigilance: 1Canada Vigilance
420Purulent dischargeCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.